(NP (NP (NP Alternate/JJ immune/JJ system/NN targets/VBZ) (PP for/IN (NP TCDD/NN)) :/:) (NP-COOD (NP lymphocyte/NN stem/NN cells/NNS) and/CC (NP extrathymic/JJ T-cell/NN development/NN) ./.))
(S (NP-SBJ We/PRP) (ADVP here/RB) (VP summarize/VBP (NP evidence/NN (SBAR that/IN (S (NP-SBJ-26 (NP thymic/JJ atrophy/NN) (VP induced/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP 2,3,7,8-tetrachlorodibenzo-p-dioxin/NN) (PRN -LRB-/-LRB- (NP TCDD/NN) -RRB-/-RRB-))))) (VP can/MD (VP be/VB (VP mediated/VBN (NP *-26/-NONE-) ,/, (PP (ADVP at/IN least/JJS) in/IN (NP part/NN)) ,/, (PP by/IN (NP-LGS (NP damage/NN) (PP to/TO (NP (NP extrathymic/JJ T-cell/NN precursors/NNS) (PP in/IN (NP-COOD (NP bone/NN marrow/NN) and/CC (NP fetal/JJ liver/NN)))))))))))))) ./.)
(S (NP-SBJ This/DT atrophy/NN induction/NN) (VP does/VBZ not/RB (VP involve/VB (NP (NP apoptotic/JJ mechanisms/NNS) (PP in/IN (NP (NP thymocytes/NNS) (VP affected/VBN (NP */-NONE-) (PP by/IN (NP-LGS the/DT bcl-2/NN proto-oncogene/NN)))))))) ./.)
(S (NP-SBJ TCDD/NN) (VP mediates/VBZ (NP atrophy/NN induction/NN) (PP-COOD (PP through/IN (NP (NP its/PRP$ specific/JJ receptor/NN) (PRN -LRB-/-LRB- (NP the/DT AhR/NN) -RRB-/-RRB-))) and/CC (PP not/RB through/IN (NP (NP effects/NNS) (PP on/IN (NP the/DT estrogen/NN receptor/NN)))))) ./.)
(S (NP-SBJ-COOD Both/CC (NP TCDD/NN) and/CC (NP estradiol/NN)) (VP induce/VBP (NP (NP extrathymic/JJ T-cell/NN differentiation/NN) (PP in/IN (NP the/DT liver/NN)))) ./.)
(S (NP-SBJ These/DT extrathymic/JJ T-cell/NN populations/NNS) (VP include/VBP (NP (NP cells/NNS) (VP expressing/VBG (NP (NP elevated/JJ levels/NNS) (PP of/IN (NP (NP V/NN beta/NN T-cell/NN receptors/NNS) (SBAR (WHNP-27 that/WDT) (S (NP-SBJ-28 *T*-27/-NONE-) (VP are/VBP (VP (ADVP normally/RB) deleted/VBN (NP *-28/-NONE-) (PP in/IN (NP thymic/JJ development/NN)))))))))))) ./.)
